Bal Pharma
BSE: 524824|NSE: BALPHARMA|ISIN: INE083D01012|SECTOR: Pharmaceuticals
LIVE
BSE
Jun 20, 15:30
16.35
0.55 (3.48%)VOLUME 208
LIVE
NSE
Jun 11, 17:00
15.25
0 VOLUME 4,425
| Download Annual Report PDF Format 2012 | 2011 | 2010 |
Key Financial Ratios of Bal Pharma |
 | ||||||||||
|
||||||||||
| Mar '12 | Mar '11 | Mar '10 | Mar '09 | Mar '08 | ||||||
|
||||||||||
| Investment Valuation Ratios | ||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| Dividend Per Share | -- | -- | -- | 0.75 | 1.00 | |||||
| Operating Profit Per Share (Rs) | 14.00 | 10.11 | 5.60 | 10.67 | 8.66 | |||||
| Net Operating Profit Per Share (Rs) | 132.11 | 109.02 | 101.02 | 98.71 | 82.07 | |||||
| Free Reserves Per Share (Rs) | -- | -- | 23.91 | 20.50 | 18.79 | |||||
| Bonus in Equity Capital | 28.75 | 28.99 | 28.99 | 28.99 | 29.10 | |||||
| Profitability Ratios | ||||||||||
| Operating Profit Margin(%) | 10.60 | 9.27 | 5.54 | 10.80 | 10.55 | |||||
| Profit Before Interest And Tax Margin(%) | 7.58 | 6.73 | 2.88 | 9.02 | 8.69 | |||||
| Gross Profit Margin(%) | 7.64 | 6.77 | 2.88 | 9.03 | 8.70 | |||||
| Cash Profit Margin(%) | 5.60 | 3.38 | -0.71 | 5.21 | 5.31 | |||||
| Adjusted Cash Margin(%) | 5.60 | 3.38 | -0.71 | 5.21 | 5.31 | |||||
| Net Profit Margin(%) | 2.66 | 0.41 | -1.26 | 2.89 | 3.25 | |||||
| Adjusted Net Profit Margin(%) | 2.66 | 0.41 | -1.26 | 2.89 | 3.25 | |||||
| Return On Capital Employed(%) | 12.96 | 8.37 | 3.54 | 10.51 | 8.88 | |||||
| Return On Net Worth(%) | 9.37 | 1.29 | -3.72 | 9.23 | 9.12 | |||||
| Adjusted Return on Net Worth(%) | 9.38 | 1.28 | -9.78 | 9.22 | 8.29 | |||||
| Return on Assets Excluding Revaluations | 37.88 | 34.82 | 34.37 | 31.01 | 29.30 | |||||
| Return on Assets Including Revaluations | 37.88 | 34.82 | 34.37 | 31.01 | 29.30 | |||||
| Return on Long Term Funds(%) | 12.96 | 8.37 | 5.59 | 14.90 | 11.83 | |||||
| Liquidity And Solvency Ratios | ||||||||||
| Current Ratio | 1.74 | 1.97 | 0.70 | 0.71 | 0.86 | |||||
| Quick Ratio | 1.07 | 1.19 | 1.19 | 1.01 | 1.16 | |||||
| Debt Equity Ratio | 1.26 | 1.58 | 1.51 | 1.26 | 1.28 | |||||
| Long Term Debt Equity Ratio | 1.26 | 1.58 | 0.59 | 0.61 | 0.71 | |||||
| Debt Coverage Ratios | ||||||||||
| Interest Cover | 1.61 | 1.16 | 0.57 | 2.26 | 2.62 | |||||
| Total Debt to Owners Fund | 1.26 | 1.58 | 1.51 | 1.26 | 1.28 | |||||
| Financial Charges Coverage Ratio | 2.18 | 1.67 | 0.95 | 2.40 | 2.72 | |||||
| Financial Charges Coverage Ratio Post Tax | 2.08 | 1.57 | 1.23 | 2.15 | 2.43 | |||||
| Management Efficiency Ratios | ||||||||||
| Inventory Turnover Ratio | 4.23 | 3.62 | 4.09 | 4.77 | 3.83 | |||||
| Debtors Turnover Ratio | 3.72 | 3.32 | 3.46 | 3.93 | 3.81 | |||||
| Investments Turnover Ratio | 4.23 | 3.62 | 4.09 | 4.77 | 3.83 | |||||
| Fixed Assets Turnover Ratio | 2.06 | 1.75 | 1.66 | 1.56 | 2.36 | |||||
| Total Assets Turnover Ratio | 1.64 | 1.29 | 1.24 | 1.22 | 1.07 | |||||
| Asset Turnover Ratio | 1.51 | 1.24 | 1.21 | 1.25 | 2.36 | |||||
| Average Raw Material Holding | -- | -- | 48.61 | 76.17 | 101.03 | |||||
| Average Finished Goods Held | -- | -- | 53.62 | 37.30 | 46.65 | |||||
| Number of Days In Working Capital | 96.26 | 126.40 | 121.62 | 85.86 | 126.66 | |||||
| Profit & Loss Account Ratios | ||||||||||
| Material Cost Composition | 54.92 | 56.72 | 61.92 | 51.39 | 50.91 | |||||
| Imported Composition of Raw Materials Consumed | 43.83 | 44.02 | 35.10 | 51.59 | 56.42 | |||||
| Selling Distribution Cost Composition | -- | -- | 9.07 | 8.59 | 9.20 | |||||
| Expenses as Composition of Total Sales | 51.12 | 55.40 | 50.86 | 33.77 | 36.47 | |||||
| Cash Flow Indicator Ratios | ||||||||||
| Dividend Payout Ratio Net Profit | -- | -- | -- | 30.63 | 43.75 | |||||
| Dividend Payout Ratio Cash Profit | -- | -- | -- | 17.02 | 25.35 | |||||
| Earning Retention Ratio | 100.00 | 100.00 | -- | 69.32 | 51.87 | |||||
| Cash Earning Retention Ratio | 100.00 | 100.00 | 100.00 | 82.96 | 73.24 | |||||
| AdjustedCash Flow Times | 6.42 | 14.82 | 26.06 | 8.74 | 9.89 | |||||
| ||||||||||
|
||||||||||
| Mar '12 | Mar '11 | Mar '10 | Mar '09 | Mar '08 | ||||||
|
||||||||||
| Earnings Per Share | 3.55 | 0.45 | -1.28 | 2.86 | 2.67 | |||||
| Book Value | 37.88 | 34.82 | 34.37 | 35.69 | 33.70 | |||||
| ||||||||||
| Source : Dion Global Solutions Limited | ||||||||||
| ||||||||||
Results of Bal Pharma
- News
- Results
- Estimates
- Analysis
Results of Pharmaceuticals Sector
- News
- Results
- Estimates
- Analysis
Quick Links for balpharma
Related Searches
balpharma Stock Price, Bal%20Pharma Stock Quote, Bal%20Pharma Results , Bal%20Pharma News ..
More »
Follow moneycontrol.com
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News |
Markets |
IPO |
Technicals |
Mutual Fund |
Commodities |
Best Portfolio Manager |
Bse Sensex |
Bombay Stock Exchange |
Share Market Live |
Recession 2011 |
Commodities Price |
Silver Price/Rate in India |
Gold Price/Rate in India |
Crude Oil |
USD to INR |
National Stock Exchange |
Bank Fixed Deposits |
Company Fixed Deposits |
Small Savings Schemes |
Property rates in India |
Rss Feeds | Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | BSE A Group Companies | BSE B Group Stocks | Union Budget
| Financial Glossary
|
Message Board |
Moneybhai |
India's Premiere Technology Guide |
History India | Davos
| Ben Bernanke | Indian rupee | Bombay Stock Exchange | Swiss National Bank | Gold | Essar Group | Villeroy and Boch | Atul Singh | NSE | Cabinet of India
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.